RxDoctor Payments Data

Stacy Slaght, APRN

Adult Health · Winter Haven, FLNPI 1740706449

Payments from drug & device makers

$3,181in general payments, 2019–2025

Across 155 payments — averaging $20.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$526
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$447
  • Amgen$346
  • Novartis$346
  • Boehringer Ingelheim$336
  • E.r. Squibb & Sons, L.L.C.$311
  • plus $869 from 8 others

What the payments were for

  • Food & beverage$3,181100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,181 in reported general payments places this provider in the 85th percentile of 2,237 adult health providers in Florida.

See all adult health providers in Florida

Medicare billing

Part B allowed, 2024
$2,079
Medicare patients
60
Services billed
152

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban461$469,289
EntrestoSacubitril/Valsartan307$344,648
JardianceEmpagliflozin117$132,781
FarxigaDapagliflozin Propanediol62$66,775
XareltoRivaroxaban58$59,204
Repatha SureclickEvolocumab72$47,779
BrilintaTicagrelor16$11,617
Metoprolol Succinate490$7,069
Dabigatran EtexilateDabigatran Etexilate Mesylate19$3,526
Irbesartan123$3,395
Losartan Potassium267$2,939
Rosuvastatin Calcium208$2,668
Amiodarone Hcl110$2,459
Isosorbide Mononitrate ErIsosorbide Mononitrate161$2,363
Carvedilol236$2,224

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$205$469,289461 claims
NovartisEntresto$346$344,648307 claims
Boehringer IngelheimJardiance$336$132,781117 claims
AstraZenecaFarxiga, Brilinta$526$78,39278 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,237 adult health providers in Florida.

Other adult health in Winter Haven

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →